Sophiris Bio (SPHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 14,839 | 9,721 | N/A |
| Marketable Securities | 33,310 | N/A | N/A |
| Receivables | 48 | 71 | N/A |
| Other current assets | 0 | 937 | 0 |
| TOTAL | $51,795 | $11,322 | $N/A |
| Non-Current Assets | |||
| PPE Net | 78 | 163 | N/A |
| Other Non-Current Assets | 19 | 44 | 0 |
| TOTAL | $97 | $207 | $N/A |
| Total Assets | $51,892 | $11,529 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,470 | 1,774 | 0 |
| Accrued Expenses | 2,181 | 2,839 | N/A |
| TOTAL | $10,528 | $10,508 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | N/A | 6,126 | N/A |
| Other Non-Current Liabilities | 1,085 | 0 | 0 |
| TOTAL | $1,085 | $6,126 | $N/A |
| Total Liabilities | $11,613 | $16,634 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 16,150 | N/A | N/A |
| Common Shares | 111,204 | 54,215 | N/A |
| Retained earnings | -84,847 | -73,698 | N/A |
| Other shareholders' equity | 98 | 5,999 | 0 |
| TOTAL | $40,279 | $-5,105 | $N/A |
| Total Liabilities And Equity | $51,892 | $11,529 | $0 |